Novis Pharmaceuticals Santa Ana, CA - 92705

Novis Pharmaceuticals is categorized under Business Services (Unclassified) in Santa Ana, CA and active since 2012.

Novis Pharmaceuticals was established in 2012, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 1790 East Mcfadden Avenue # 107, Santa Ana, California CA 92705 or by phoning (714) 568-5329. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Novis Pharmaceuticals
Address: 1790 East Mcfadden Avenue # 107, Santa Ana, California 92705
Phone Number: (714) 568-5329
Website Address: novispharma.com
Annual Revenue (USD): $100.000.000 to $499.999.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Novis Pharmaceuticals was started in 2012 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.

Feel free to contact for inquiries that concern Novis Pharmaceuticals by calling the company number (714) 568-5329, as your correspondence is most welcome. Additionally, the physical location of the single location of Novis Pharmaceuticals can be found at the coordinates 33.73371,-117.84252 as well as the street address 1790 East Mcfadden Avenue # 107 in Santa Ana, California 92705.

For its online presence, you may visit Novis Pharmaceuticals’s website at novispharma.com and engage with its social media outlets through on Twitter and on Facebook.